Prestige Consumer Healthcare closes $150 million LaCorium deal, prices $400 million notes
Prestige Consumer Healthcare completed its acquisition of LaCorium Health on July 1, 2026, for approximately $150 million in cash, and priced a $400 million offering of 6.25% senior notes due 2034. The company plans to use the notes proceeds, with cash on hand, to redeem its $400 million of 5.125% senior notes due 2028, which changes its interest expense. The filing reports no earnings figures, and the company will report first quarter fiscal 2027 results on August 6, 2026.
Key points
- Acquisition of LaCorium Health closed July 1, 2026, for approximately $150 million in cash, financed with cash on hand and existing credit facilities
- Borrower drew $95.0 million of additional term loans under a July 1, 2026 amendment to its credit agreement
- $400 million of 6.25% senior notes due 2034 priced, with closing expected on or about July 15, 2026, to redeem the 5.125% notes due 2028
- LaCorium generates approximately $40 million in annual revenue and is expected to generate approximately $12 million in EBITDA once integrated
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 06, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.